Delivering optimal renal replacement therapy to critically ill patients with acute kidney injury.

Acute Kidney Injury Critical Illness / therapy Humans Intensive Care Units Renal Replacement Therapy
Acute kidney injury Clinical trials Intensive care unit Renal replacement therapy

Journal

Intensive care medicine
ISSN: 1432-1238
Titre abrégé: Intensive Care Med
Pays: United States
ID NLM: 7704851

Informations de publication

Date de publication:
10 2022
Historique:
received: 04 05 2022
accepted: 29 07 2022
pubmed: 7 9 2022
medline: 15 9 2022
entrez: 6 9 2022
Statut: ppublish

Résumé

Critical illness is often complicated by acute kidney injury (AKI). In patients with severe AKI, renal replacement therapy (RRT) is deployed to address metabolic dysfunction and volume excess until kidney function recovers. This review is intended to provide a comprehensive update on key aspects of RRT prescription and delivery to critically ill patients. Recently completed trials have enhanced the evidence base regarding several RRT practices, most notably the timing of RRT initiation and anticoagulation for continuous therapies. Better evidence is still needed to clarify several aspects of care including optimal targets for ultrafiltration and effective strategies for RRT weaning and discontinuation.

Identifiants

DOI: 10.1007/s00134-022-06851-6 PMID: 36066597
pubmed: 36066597
doi: 10.1007/s00134-022-06851-6
pii: 10.1007/s00134-022-06851-6
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1368-1381

Informations de copyright

© 2022. Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Hoste EAJ, Kellum JA, Selby NM, Zarbock A, Palevsky PM, Bagshaw SM, Goldstein SL, Cerda J, Chawla LS (2018) Global epidemiology and outcomes of acute kidney injury. Nat Rev Nephrol 14(10):607–625
pubmed: 30135570 doi: 10.1038/s41581-018-0052-0
Bagshaw SM, Darmon M, Ostermann M, Finkelstein FO, Wald R, Tolwani AJ, Goldstein SL, Gattas DJ, Uchino S, Hoste EA, Gaudry S (2017) Current state of the art for renal replacement therapy in critically ill patients with acute kidney injury. Intensive Care Med 43(6):841–854
pubmed: 28289816 doi: 10.1007/s00134-017-4762-8
Zarbock A, Kellum JA, Schmidt C, Van Aken H, Wempe C, Pavenstadt H, Boanta A, Gerss J, Meersch M (2016) Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial. JAMA 315(20):2190–2199
pubmed: 27209269 doi: 10.1001/jama.2016.5828
Gaudry S, Hajage D, Schortgen F, Martin-Lefevre L, Pons B, Boulet E, Boyer A, Chevrel G, Lerolle N, Carpentier D, de Prost N, Lautrette A, Bretagnol A, Mayaux J, Nseir S, Megarbane B, Thirion M, Forel JM, Maizel J, Yonis H, Markowicz P, Thiery G, Tubach F, Ricard JD, Dreyfuss D, Group AS (2016) Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med 375(2):122–133
doi: 10.1056/NEJMoa1603017
Barbar SD, Clere-Jehl R, Bourredjem A, Hernu R, Montini F, Bruyere R, Lebert C, Bohe J, Badie J, Eraldi JP, Rigaud JP, Levy B, Siami S, Louis G, Bouadma L, Constantin JM, Mercier E, Klouche K, du Cheyron D, Piton G, Annane D, Jaber S, van der Linden T, Blasco G, Mira JP, Schwebel C, Chimot L, Guiot P, Nay MA, Meziani F, Helms J, Roger C, Louart B, Trusson R, Dargent A, Binquet C, Quenot JP, Investigators I-IT, the CTN (2018) Timing of renal-replacement therapy in patients with acute kidney injury and sepsis. N Engl J Med 379(15):1431–1442
pubmed: 30304656 doi: 10.1056/NEJMoa1803213
Investigators T-AKI, Bagshaw SM, Wald R, Adhikari NKJ, Bellomo R, da Costa BR, Dreyfuss D, Du B, Gallagher MP, Gaudry S, Hoste EA, Lamontagne F, Joannidis M, Landoni G, Liu KD, McAuley DF, McGuinness SP, Neyra JA, Nichol AD, Ostermann M, Palevsky PM, Pettila V, Quenot JP, Qiu H, Rochwerg B, Schneider AG, Smith OM, Thome F, Thorpe KE, Vaara S, Weir M, Wang AY, Young P, Zarbock A (2020) Timing of initiation of renal-replacement therapy in acute kidney injury. N Engl J Med 383(3):240–251
doi: 10.1056/NEJMoa2000741
Gaudry S, Hajage D, Martin-Lefevre L, Lebbah S, Louis G, Moschietto S, Titeca-Beauport D, Combe B, Pons B, de Prost N, Besset S, Combes A, Robine A, Beuzelin M, Badie J, Chevrel G, Bohe J, Coupez E, Chudeau N, Barbar S, Vinsonneau C, Forel JM, Thevenin D, Boulet E, Lakhal K, Aissaoui N, Grange S, Leone M, Lacave G, Nseir S, Poirson F, Mayaux J, Asehnoune K, Geri G, Klouche K, Thiery G, Argaud L, Rozec B, Cadoz C, Andreu P, Reignier J, Ricard JD, Quenot JP, Dreyfuss D (2021) Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial. Lancet 397(10281):1293–1300
pubmed: 33812488 doi: 10.1016/S0140-6736(21)00350-0
Klein SJ, Brandtner AK, Lehner GF, Ulmer H, Bagshaw SM, Wiedermann CJ, Joannidis M (2018) Biomarkers for prediction of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis. Intensive Care Med 44(3):323–336
pubmed: 29541790 pmcid: 5861176 doi: 10.1007/s00134-018-5126-8
Hoste E, Bihorac A, Al-Khafaji A, Ortega LM, Ostermann M, Haase M, Zacharowski K, Wunderink R, Heung M, Lissauer M, Self WH, Koyner JL, Honore PM, Prowle JR, Joannidis M, Forni LG, Kampf JP, McPherson P, Kellum JA, Chawla LS (2020) Identification and validation of biomarkers of persistent acute kidney injury: the RUBY study. Intensive Care Med 46(5):943–953
pubmed: 32025755 pmcid: 7210248 doi: 10.1007/s00134-019-05919-0
Bagshaw SM, Al-Khafaji A, Artigas A, Davison D, Haase M, Lissauer M, Zacharowski K, Chawla LS, Kwan T, Kampf JP, McPherson P, Kellum JA (2021) External validation of urinary C-C motif chemokine ligand 14 (CCL14) for prediction of persistent acute kidney injury. Crit Care 25(1):185
pubmed: 34059102 pmcid: 8166095 doi: 10.1186/s13054-021-03618-1
Chen JJ, Chang CH, Huang YT, Kuo G (2020) Furosemide stress test as a predictive marker of acute kidney injury progression or renal replacement therapy: a systemic review and meta-analysis. Crit Care 24(1):202
pubmed: 32381019 pmcid: 7206785 doi: 10.1186/s13054-020-02912-8
Edrees F, Li T, Vijayan A (2016) Prolonged intermittent renal replacement therapy. Adv Chronic Kidney Dis 23(3):195–202
pubmed: 27113696 doi: 10.1053/j.ackd.2016.03.003
Phu NH, Hien TT, Mai NT, Chau TT, Chuong LV, Loc PP, Winearls C, Farrar J, White N, Day N (2002) Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam. N Engl J Med 347(12):895–902
pubmed: 12239258 doi: 10.1056/NEJMoa020074
Fisher R, Clarke J, Al-Arfi K, Saha R, Lioudaki E, Mehta R, Pahl C, Sharpe C, Bramham K, Hutchings S (2021) Provision of acute renal replacement therapy, using three separate modalities, in critically ill patients during the COVID-19 pandemic. An after action review from a UK tertiary critical care centre. J Crit Care 62:190–196
pubmed: 33422809 doi: 10.1016/j.jcrc.2020.12.023
Zhou X, Dong P, Pan J, Wang H, Xu Z, Chen B (2021) Renal replacement therapy modality in critically ill patients with acute kidney injury—a network meta-analysis of randomized controlled trials. J Crit Care 64:82–90
pubmed: 33836397 doi: 10.1016/j.jcrc.2021.03.011
Panaput T, Peerapornratana S, Sirivongrangson P, Kulvichit W, Lumlertgul N, Jonny J, Praditpornsilpa K, Tungsanga K, Eiam-Ong S, Srisawat N (2021) Modalities of renal replacement therapy and clinical outcomes of patients with acute kidney injury in a resource-limited setting: results from a SEA-AKI study. J Crit Care 65:18–25
pubmed: 34058688 doi: 10.1016/j.jcrc.2021.05.006
Matsuura R, Doi K, Hamasaki Y, Nangaku M (2020) RRT selection for AKI patients with critical illness. Semin Nephrol 40(5):498–505
Truche AS, Darmon M, Bailly S, Clec’h C, Dupuis C, Misset B, Azoulay E, Schwebel C, Bouadma L, Kallel H, Adrie C, Dumenil AS, Argaud L, Marcotte G, Jamali S, Zaoui P, Laurent V, Goldgran-Toledano D, Sonneville R, Souweine B, Timsit JF, Group OS (2016) Continuous renal replacement therapy versus intermittent hemodialysis in intensive care patients: impact on mortality and renal recovery. Intensive Care Med 42(9):1408–1417
doi: 10.1007/s00134-016-4404-6
Schneider AG, Bellomo R, Bagshaw SM, Glassford NJ, Lo S, Jun M, Cass A, Gallagher M (2013) Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury: a systematic review and meta-analysis. Intensive Care Med 39(6):987–997
pubmed: 23443311 doi: 10.1007/s00134-013-2864-5
Zhang L, Yang J, Eastwood GM, Zhu G, Tanaka A, Bellomo R (2015) Extended daily dialysis versus continuous renal replacement therapy for acute kidney injury: a meta-analysis. Am J Kidney Dis 66(2):322–330
pubmed: 25843704 doi: 10.1053/j.ajkd.2015.02.328
Liang KV, Sileanu FE, Clermont G, Murugan R, Pike F, Palevsky PM, Kellum JA (2016) Modality of RRT and recovery of kidney function after AKI in patients surviving to hospital discharge. Clin J Am Soc Nephrol 11(1):30–38
pubmed: 26681135 doi: 10.2215/CJN.01290215
Gaudry S, Palevsky PM, Dreyfuss D (2022) Extracorporeal kidney-replacement therapy for acute kidney injury. N Engl J Med 386(10):964–975
pubmed: 35263520 doi: 10.1056/NEJMra2104090
Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C (2005) Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294(7):813–818
pubmed: 16106006 doi: 10.1001/jama.294.7.813
Ostermann M, Bellomo R, Burdmann EA, Doi K, Endre ZH, Goldstein SL, Kane-Gill SL, Liu KD, Prowle JR, Shaw AD, Srisawat N, Cheung M, Jadoul M, Winkelmayer WC, Kellum JA, Conference P (2020) Controversies in acute kidney injury: conclusions from a Kidney Disease: improving Global Outcomes (KDIGO) Conference. Kidney Int 98(2):294–309
Beaubien-Souligny W, Yang Y, Burns KEA, Friedrich JO, Meraz-Munoz A, Clark EG, Adhikari NK, Bagshaw SM, Wald R (2021) Intra-dialytic hypotension following the transition from continuous to intermittent renal replacement therapy. Ann Intensive Care 11(1):96
pubmed: 34146164 pmcid: 8214642 doi: 10.1186/s13613-021-00885-7
Douvris A, Zeid K, Hiremath S, Bagshaw SM, Wald R, Beaubien-Souligny W, Kong J, Ronco C, Clark EG (2019) Mechanisms for hemodynamic instability related to renal replacement therapy: a narrative review. Intensive Care Med 45(10):1333–1346
pubmed: 31407042 pmcid: 6773820 doi: 10.1007/s00134-019-05707-w
Silversides JA, Pinto R, Kuint R, Wald R, Hladunewich MA, Lapinsky SE, Adhikari NK (2014) Fluid balance, intradialytic hypotension, and outcomes in critically ill patients undergoing renal replacement therapy: a cohort study. Crit Care 18(6):624
pubmed: 25407408 pmcid: 4255668 doi: 10.1186/s13054-014-0624-8
Mahmoud H, Forni LG, McIntyre CW, Selby NM (2017) Myocardial stunning occurs during intermittent haemodialysis for acute kidney injury. Intensive Care Med 43(6):942–944
pubmed: 28352974 pmcid: 5487536 doi: 10.1007/s00134-017-4768-2
Slessarev M, Salerno F, Ball IM, McIntyre CW (2019) Continuous renal replacement therapy is associated with acute cardiac stunning in critically ill patients. Hemodial Int
Douvris A, Malhi G, Hiremath S, McIntyre L, Silver SA, Bagshaw SM, Wald R, Ronco C, Sikora L, Weber C, Clark EG (2018) Interventions to prevent hemodynamic instability during renal replacement therapy in critically ill patients: a systematic review. Crit Care 22(1):41
pubmed: 29467008 pmcid: 5822560 doi: 10.1186/s13054-018-1965-5
Macedo E, Karl B, Lee E, Mehta RL (2021) A randomized trial of albumin infusion to prevent intradialytic hypotension in hospitalized hypoalbuminemic patients. Crit Care 25(1):18
pubmed: 33407747 pmcid: 7789619 doi: 10.1186/s13054-020-03441-0
Clark EG, McIntyre L, Watpool I, Kong JWY, Ramsay T, Sabri E, Canney M, Hundemer GL, Brown PA, Sood MM, Hiremath S (2021) Intravenous albumin for the prevention of hemodynamic instability during sustained low-efficiency dialysis: a randomized controlled feasibility trial (The SAFER-SLED Study). Ann Intensive Care 11(1):174
pubmed: 34902089 pmcid: 8669086 doi: 10.1186/s13613-021-00962-x
Bonavia A, Miller L, Kellum JA, Singbartl K (2017) Hemoadsorption corrects hyperresistinemia and restores anti-bacterial neutrophil function. Intensive Care Med Exp 5(1):36
pubmed: 28779451 pmcid: 5544662 doi: 10.1186/s40635-017-0150-5
Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P (2001) High-volume haemofiltration in human septic shock. Intensive Care Med 27(6):978–986
pubmed: 11497156 doi: 10.1007/s001340100963
Chung KK, Coates EC, Smith DJ Jr, Karlnoski RA, Hickerson WL, Arnold-Ross AL, Mosier MJ, Halerz M, Sprague AM, Mullins RF, Caruso DM, Albrecht M, Arnoldo BD, Burris AM, Taylor SL, Wolf SE (2017) High-volume hemofiltration in adult burn patients with septic shock and acute kidney injury: a multicenter randomized controlled trial. Crit Care 21(1):289
pubmed: 29178943 pmcid: 5702112 doi: 10.1186/s13054-017-1878-8
Wald R, Friedrich JO, Bagshaw SM, Burns KE, Garg AX, Hladunewich MA, House AA, Lapinsky S, Klein D, Pannu NI, Pope K, Richardson RM, Thorpe K, Adhikari NK (2012) Optimal Mode of clearance in critically ill patients with Acute Kidney Injury (OMAKI)—a pilot randomized controlled trial of hemofiltration versus hemodialysis: a Canadian Critical Care Trials Group project. Crit Care 16(5):R205
pubmed: 23095370 pmcid: 3682309 doi: 10.1186/cc11835
Clark E, Molnar AO, Joannes-Boyau O, Honoré PM, Sikora L, Bagshaw SM (2014) High-volume hemofiltration for septic acute kidney injury: a systematic review and meta-analysis. Crit Care 18(1):R7
pubmed: 24398168 pmcid: 4057068 doi: 10.1186/cc13184
Borthwick EM, Hill CJ, Rabindranath KS, Maxwell AP, McAuley DF, Blackwood B (2017) High-volume haemofiltration for sepsis in adults. Cochrane Database Syst Rev 1(1):Cd008075
Côté JM, Pinard L, Cailhier JF, Lévesque R, Murray PT, Beaubien-Souligny W (2022) Intermittent convective therapies in patients with acute kidney injury: a systematic review with meta-analysis. Blood Purif 51(1):75–86
pubmed: 33902049 doi: 10.1159/000515641
Broman ME, Hansson F, Vincent JL, Bodelsson M (2019) Endotoxin and cytokine reducing properties of the oXiris membrane in patients with septic shock: a randomized crossover double-blind study. PLoS ONE 14(8):e0220444
pubmed: 31369593 pmcid: 6675097 doi: 10.1371/journal.pone.0220444
Malard B, Lambert C, Kellum JA (2018) In vitro comparison of the adsorption of inflammatory mediators by blood purification devices. Intensive Care Med Exp 6(1):12
pubmed: 29728790 pmcid: 5935601 doi: 10.1186/s40635-018-0177-2
Garbero E, Livigni S, Ferrari F, Finazzi S, Langer M, Malacarne P, Meca MCC, Mosca S, Olivieri C, Pozzato M, Rossi C, Tavola M, Terzitta M, Viaggi B, Bertolini G (2021) High dose coupled plasma filtration and adsorption in septic shock patients. Results of the COMPACT-2: a multicentre, adaptive, randomised clinical trial. Intensive Care Med 47(11):1303–1311
Putzu A, Schorer R, Lopez-Delgado JC, Cassina T, Landoni G (2019) Blood purification and mortality in sepsis and septic shock: a systematic review and meta-analysis of randomized trials. Anesthesiology 131(3):580–593
pubmed: 31246600 doi: 10.1097/ALN.0000000000002820
Nih Acute Renal Failure Trial Network VA, Palevsky PM, Zhang JH, O’Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P (2008) Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359(1):7–20
doi: 10.1056/NEJMoa0802639
RENAL Study Investigators, Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C, Su S (2009) Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 361(17):1627–1638
doi: 10.1056/NEJMoa0902413
Rosner MH, Connor MJ Jr (2018) Management of severe hyponatremia with continuous renal replacement therapies. Clin J Am Soc Nephrol 13(5):787–789
pubmed: 29463598 pmcid: 5969490 doi: 10.2215/CJN.13281117
Ostermann M, Dickie H, Tovey L, Treacher D (2010) Management of sodium disorders during continuous haemofiltration. Crit Care 14(3):418
pubmed: 20519032 pmcid: 2911705 doi: 10.1186/cc9002
Yessayan L, Yee J, Frinak S, Szamosfalvi B (2014) Treatment of severe hyponatremia in patients with kidney failure: role of continuous venovenous hemofiltration with low-sodium replacement fluid. Am J Kidney Dis 64(2):305–310
pubmed: 24792353 doi: 10.1053/j.ajkd.2014.01.451
Neyra JA, Ortiz-Soriano VM, Ali D, Morris PE, Johnston CM (2019) A multidisciplinary approach for the management of severe hyponatremia in patients requiring continuous renal replacement therapy. Kidney Int Rep 4(1):59–66
pubmed: 30596169 doi: 10.1016/j.ekir.2018.09.001
Demirjian S, Teo BW, Guzman JA, Heyka RJ, Paganini EP, Fissell WH, Schold JD, Schreiber MJ (2011) Hypophosphatemia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury. Nephrol Dial Transpl 26(11):3508–3514
doi: 10.1093/ndt/gfr075
Thompson Bastin ML, Adams PM, Nerusu S, Morris PE, Mayer KP, Neyra JA (2022) Association of phosphate containing solutions with incident hypophosphatemia in critically ill patients requiring continuous renal replacement therapy. Blood Purif 51(2):122–129
pubmed: 33915554 doi: 10.1159/000514418
Thompson Bastin ML, Stromberg AJ, Nerusu SN, Liu LJ, Mayer KP, Liu KD, Bagshaw SM, Wald R, Morris PE, Neyra JA (2022) Association of phosphate-containing versus phosphate-free solutions on ventilator days in patients requiring continuous kidney replacement therapy. Clin J Am Soc Nephrol
Coutrot M, Hekimian G, Moulin T, Brechot N, Schmidt M, Besset S, Nieszkowska A, Franchineau G, Bourcier S, Bourron O, Luyt CE, Combes A (2018) Euglycemic ketoacidosis, a common and underecognized complication of continuous renal replacement therapy using glucose-free solutions. Intensive Care Med 44(7):1185–1186
pubmed: 29536124 doi: 10.1007/s00134-018-5118-8
Ting S, Chua HR, Cove ME (2021) Euglycemic ketosis during continuous kidney replacement therapy with glucose-free solution: a report of 8 cases. Am J Kidney Dis 78(2):305–308
pubmed: 33278477 doi: 10.1053/j.ajkd.2020.10.014
Stevens JS, Salazar-Schicchi J, Radhakrishnan J, Mohan S (2021) The case|euglycemic ketoacidosis in a patient on continuous renal replacement therapy. Kidney Int 99(6):1507–1508
pubmed: 34023035 doi: 10.1016/j.kint.2020.12.025
Tolwani AJ, Prendergast MB, Speer RR, Stofan BS, Wille KM (2006) A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance. Clin J Am Soc Nephrol 1(1):79–87
pubmed: 17699194 doi: 10.2215/CJN.00040505
Tsujimoto H, Tsujimoto Y, Nakata Y, Fujii T, Takahashi S, Akazawa M, Kataoka Y (2020) Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy. Cochrane Database Syst Rev 12:CD012467
Zarbock A, Kullmar M, Kindgen-Milles D, Wempe C, Gerss J, Brandenburger T, Dimski T, Tyczynski B, Jahn M, Mulling N, Mehrlander M, Rosenberger P, Marx G, Simon TP, Jaschinski U, Deetjen P, Putensen C, Schewe JC, Kluge S, Jarczak D, Slowinski T, Bodenstein M, Meybohm P, Wirtz S, Moerer O, Kortgen A, Simon P, Bagshaw SM, Kellum JA, Meersch M, Investigators R, the Sepnet Trial G, (2020) Effect of regional citrate anticoagulation vs systemic heparin anticoagulation during continuous kidney replacement therapy on dialysis filter life span and mortality among critically ill patients with acute kidney injury: a randomized clinical trial. JAMA 324(16):1629–1639
pubmed: 33095849 doi: 10.1001/jama.2020.18618
Slowinski T, Morgera S, Joannidis M, Henneberg T, Stocker R, Helset E, Andersson K, Wehner M, Kozik-Jaromin J, Brett S, Hasslacher J, Stover JF, Peters H, Neumayer HH, Kindgen-Milles D (2015) Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study. Crit Care 19:349
pubmed: 26415638 pmcid: 4587580 doi: 10.1186/s13054-015-1066-7
Klingele M, Stadler T, Fliser D, Speer T, Groesdonk HV, Raddatz A (2017) Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction. Crit Care 21(1):294
pubmed: 29187232 pmcid: 5707786 doi: 10.1186/s13054-017-1870-3
Malbrain M, Van Regenmortel N, Saugel B, De Tavernier B, Van Gaal PJ, Joannes-Boyau O, Teboul JL, Rice TW, Mythen M, Monnet X (2018) Principles of fluid management and stewardship in septic shock: it is time to consider the four D’s and the four phases of fluid therapy. Ann Intensive Care 8(1):66
pubmed: 29789983 pmcid: 5964054 doi: 10.1186/s13613-018-0402-x
Messmer AS, Zingg C, Müller M, Gerber JL, Schefold JC, Pfortmueller CA (2020) Fluid overload and mortality in adult critical care patients—a systematic review and meta-analysis of observational studies. Crit Care Med 48(12):1862–1870
pubmed: 33009098 doi: 10.1097/CCM.0000000000004617
Woodward CW, Lambert J, Ortiz-Soriano V, Li Y, Ruiz-Conejo M, Bissell BD, Kelly A, Adams P, Yessayan L, Morris PE, Neyra JA (2019) Fluid overload associates with major adverse kidney events in critically ill patients with acute kidney injury requiring continuous renal replacement therapy. Crit Care Med 47(9):e753–e760
pubmed: 31162196 doi: 10.1097/CCM.0000000000003862
Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lee J, Lo S, McArthur C, McGuiness S, Norton R, Myburgh J, Scheinkestel C, Su S (2012) An observational study fluid balance and patient outcomes in the Randomized Evaluation of Normal vs. Augmented Level of Replacement Therapy trial. Crit Care Med 40(6):1753–1760
Murugan R, Kerti SJ, Chang CH, Gallagher M, Clermont G, Palevsky PM, Kellum JA, Bellomo R (2019) Association of net ultrafiltration rate with mortality among critically ill adults with acute kidney injury receiving continuous venovenous hemodiafiltration: a secondary analysis of the randomized evaluation of normal vs augmented level (RENAL) of renal replacement therapy trial. JAMA Netw Open 2(6):e195418
pubmed: 31173127 pmcid: 6563576 doi: 10.1001/jamanetworkopen.2019.5418
Katulka RJ, Al Saadon A, Sebastianski M, Featherstone R, Vandermeer B, Silver SA, Gibney RTN, Bagshaw SM, Rewa OG (2020) Determining the optimal time for liberation from renal replacement therapy in critically ill patients: a systematic review and meta-analysis (DOnE RRT). Crit Care 24(1):50
pubmed: 32054522 pmcid: 7020497 doi: 10.1186/s13054-020-2751-8
Baeg SI, Jeon J, Yoo H, Na SJ, Kim K, Chung CR, Yang JH, Jeon K, Lee JE, Huh W, Suh GY, Kim YG, Kim DJ, Jang HR (2021) A scoring model with simple clinical parameters to predict successful discontinuation of continuous renal replacement therapy. Blood Purif 50(6):779–789
pubmed: 33735858 doi: 10.1159/000512350
Liu C, Peng Z, Dong Y, Li Z, Andrijasevic NM, Albright RC Jr, Kashani KB (2021) Predicting successful continuous renal replacement therapy liberation in critically ill patients with acute kidney injury. J Crit Care 66:6–13
pubmed: 34358675 doi: 10.1016/j.jcrc.2021.07.020
Chanchlani R, Nash DM, McArthur E, Zappitelli M, Archer V, Kuwornu JP, Garg AX, Greenberg JH, Goldstein SL, Thabane L, Wald R (2019) Secular trends in incidence, modality and mortality with dialysis receiving AKI in children in Ontario: a population-based cohort study. Clin J Am Soc Nephrol 14(9):1288–1296
pubmed: 31444174 pmcid: 6730522 doi: 10.2215/CJN.08250718
Robinson CH, Jeyakumar N, Luo B, Wald R, Garg AX, Nash DM, McArthur E, Greenberg JH, Askenazi D, Mammen C, Thabane L, Goldstein S, Parekh RS, Zappitelli M, Chanchlani R (2021) Long-term kidney outcomes following dialysis-treated childhood acute kidney injury: a population-based cohort study. J Am Soc Nephrol 32(8):2005–2019
pubmed: 34039667 pmcid: 8455253 doi: 10.1681/ASN.2020111665
Mammen C, Al Abbas A, Skippen P, Nadel H, Levine D, Collet JP, Matsell DG (2012) Long-term risk of CKD in children surviving episodes of acute kidney injury in the intensive care unit: a prospective cohort study. Am J Kidney Dis 59(4):523–530
pubmed: 22206744 doi: 10.1053/j.ajkd.2011.10.048
Hessey E, Morissette G, Lacroix J, Perreault S, Samuel S, Dorais M, Phan V, Jouvet P, Lafrance JP, LeLorier J, Palijan A, Pizzi M, Roy L, Zappitelli M (2018) Healthcare utilization after acute kidney injury in the pediatric intensive care unit. Clin J Am Soc Nephrol 13(5):685–692
pubmed: 29678895 pmcid: 5969475 doi: 10.2215/CJN.09350817
Kaddourah A, Basu RK, Bagshaw SM, Goldstein SL (2017) Epidemiology of acute kidney injury in critically ill children and young adults. N Engl J Med 376(1):11–20
pubmed: 27959707 doi: 10.1056/NEJMoa1611391
Li S, Krawczeski CD, Zappitelli M, Devarajan P, Thiessen-Philbrook H, Coca SG, Kim RW, Parikh CR (2011) Incidence, risk factors, and outcomes of acute kidney injury after pediatric cardiac surgery: a prospective multicenter study. Crit Care Med 39(6):1493–1499
pubmed: 21336114 pmcid: 3286600 doi: 10.1097/CCM.0b013e31821201d3
Morgan CJ, Zappitelli M, Robertson CM, Alton GY, Sauve RS, Joffe AR, Ross DB, Rebeyka IM (2013) Risk factors for and outcomes of acute kidney injury in neonates undergoing complex cardiac surgery. J Pediatr 162(1):120-127.e121
pubmed: 22878115 doi: 10.1016/j.jpeds.2012.06.054
Jetton JG, Boohaker LJ, Sethi SK, Wazir S, Rohatgi S, Soranno DE, Chishti AS, Woroniecki R, Mammen C, Swanson JR, Sridhar S, Wong CS, Kupferman JC, Griffin RL, Askenazi DJ (2017) Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicentre, multinational, observational cohort study. Lancet Child Adolesc Health 1(3):184–194
pubmed: 29732396 pmcid: 5933049 doi: 10.1016/S2352-4642(17)30069-X
Starr MC, Charlton JR, Guillet R, Reidy K, Tipple TE, Jetton JG, Kent AL, Abitbol CL, Ambalavanan N, Mhanna MJ, Askenazi DJ, Selewski DT, Harer MW (2021) Advances in neonatal acute kidney injury. Pediatrics 148(5)
Askenazi D, Ingram D, White S, Cramer M, Borasino S, Coghill C, Dill L, Tenney F, Feig D, Fathallah-Shaykh S (2016) Smaller circuits for smaller patients: improving renal support therapy with Aquadex™. Pediatr Nephrol 31(5):853–860
pubmed: 26572894 doi: 10.1007/s00467-015-3259-3
Reznik VM, Randolph G, Collins CM, Peterson BM, Lemire JM, Mendoza SA (1993) Cost analysis of dialysis modalities for pediatric acute renal failure. Perit Dial Int 13(4):311–313
pubmed: 8241334 doi: 10.1177/089686089301300410
Flynn JT (2002) Choice of dialysis modality for management of pediatric acute renal failure. Pediatr Nephrol 17(1):61–69
pubmed: 11793137 doi: 10.1007/s004670200011
Burgmaier K, Hackl A, Ehren R, Kribs A, Burgmaier M, Weber LT, Oberthuer A, Habbig S (2020) Peritoneal dialysis in extremely and very low-birth-weight infants. Perit Dial Int 40(2):233–236
pubmed: 32063199 doi: 10.1177/0896860819887292
Stojanović VD, Bukarica SS, Antić JB, Doronjski AD (2017) Peritoneal dialysis in very low birth weight neonates. Perit Dial Int 37(4):389–396
pubmed: 28676510 doi: 10.3747/pdi.2016.00039
Barhight MF, Soranno D, Faubel S, Gist KM (2018) Fluid management with peritoneal dialysis after pediatric cardiac surgery. World J Pediatr Congenit Heart Surg 9(6):696–704
pubmed: 30322362 doi: 10.1177/2150135118800699
Guzzo I, de Galasso L, Mir S, Bulut IK, Jankauskiene A, Burokiene V, Cvetkovic M, Kostic M, Bayazit AK, Yildizdas D, Schmitt CP, Paglialonga F, Montini G, Yilmaz E, Oh J, Weber L, Taylan C, Hayes W, Shroff R, Vidal E, Murer L, Mencarelli F, Pasini A, Teixeira A, Afonso AC, Drozdz D, Schaefer F, Picca S (2019) Acute dialysis in children: results of a European survey. J Nephrol 32(3):445–451
pubmed: 30949986 doi: 10.1007/s40620-019-00606-1
Nourse P, Cullis B, Finkelstein F, Numanoglu A, Warady B, Antwi S, McCulloch M (2021) ISPD guidelines for peritoneal dialysis in acute kidney injury: 2020 Update (paediatrics). Perit Dial Int 41(2):139–157
pubmed: 33523772 doi: 10.1177/0896860820982120
Ansari N (2011) Peritoneal dialysis in renal replacement therapy for patients with acute kidney injury. Int J Nephrol 2011:739794
pubmed: 21716704 pmcid: 3118664 doi: 10.4061/2011/739794
Vasudevan A, Phadke K, Yap HK (2017) Peritoneal dialysis for the management of pediatric patients with acute kidney injury. Pediatr Nephrol 32(7):1145–1156
pubmed: 27796620 doi: 10.1007/s00467-016-3482-6
Agrawal A, Nolph KD (2000) Advantages of tidal peritoneal dialysis. Perit Dial Int 20(Suppl 2):S98-100
pubmed: 10911652 doi: 10.1177/089686080002002S19
Gabriel DP, Nascimento GV, Caramori JT, Martim LC, Barretti P, Balbi AL (2007) High volume peritoneal dialysis for acute renal failure. Perit Dial Int 27(3):277–282
pubmed: 17468475 doi: 10.1177/089686080702700312
Raaijmakers R, Schröder CH, Gajjar P, Argent A, Nourse P (2011) Continuous flow peritoneal dialysis: first experience in children with acute renal failure. Clin J Am Soc Nephrol 6(2):311–318
pubmed: 21030578 pmcid: 3052221 doi: 10.2215/CJN.00330110
HK Yap LR. Peritoneal dialysis in critically ill children. . In: Goldstein ADaSL, ed. Critical care nephrology and renal replacement therapy in children. Springer; 2018.
Raina R, McCulloch M, Nourse P, Sethi SK, Yap HK (2021) Advances in kidney replacement therapy in infants. Adv Chronic Kidney Dis 28(1):91–104
pubmed: 34389141 doi: 10.1053/j.ackd.2021.05.002
Munshi R, Lee-Son K, Hackbarth RM, Quigley R, Sutherland SM, Echeverri J, Goldstein SL (2020) Clinical evaluation of the Prismaflex™ HF 20 set and Prismaflex™ system 7.10 for acute continuous kidney replacement therapy (CKRT) in children. Pediatr Nephrol 35(12):2345–2352
Liu ID, Ng KH, Lau PY, Yeo WS, Koh PL, Yap HK (2013) Use of HF20 membrane in critically ill unstable low-body-weight infants on inotropic support. Pediatr Nephrol 28(5):819–822
pubmed: 23306707 doi: 10.1007/s00467-012-2394-3
Santiago MJ, López-Herce J (2011) Prismaflex HF20 for continuous renal replacement therapy in critically ill children. Artif Organs 35(12):1194
pubmed: 21973166 doi: 10.1111/j.1525-1594.2011.01367.x
Vidal E, Garzotto F, Parolin M, Manenti C, Zanin A, Bellettato M, Remuzzi G, Goldstein SL, Murer L, Ronco C (2017) Therapeutic plasma exchange in neonates and infants: successful use of a miniaturized machine. Blood Purif 44(2):100–105
pubmed: 28715820 doi: 10.1159/000470827
Garzotto F, Vidal E, Ricci Z, Paglialonga F, Giordano M, Laforgia N, Peruzzi L, Bellettato M, Murer L, Ronco C (2020) Continuous kidney replacement therapy in critically ill neonates and infants: a retrospective analysis of clinical results with a dedicated device. Pediatr Nephrol 35(9):1699–1705
pubmed: 32440948 doi: 10.1007/s00467-020-04562-y
Goldstein SL, Vidal E, Ricci Z, Paglialonga F, Peruzzi L, Giordano M, Laforgia N, Ronco C (2022) Survival of infants treated with CKRT: comparing adapted adult platforms with the Carpediem™. Pediatr Nephrol 37(3):667–675
pubmed: 34414499 doi: 10.1007/s00467-021-05180-y
Menon S, Broderick J, Munshi R, Dill L, DePaoli B, Fathallah-Shaykh S, Claes D, Goldstein SL, Askenazi DJ (2019) Kidney support in children using an ultrafiltration device: a multicenter, retrospective study. Clin J Am Soc Nephrol 14(10):1432–1440
pubmed: 31462396 pmcid: 6777586 doi: 10.2215/CJN.03240319
Coulthard MG, Crosier J, Griffiths C, Smith J, Drinnan M, Whitaker M, Beckwith R, Matthews JN, Flecknell P, Lambert HJ (2014) Haemodialysing babies weighing <8 kg with the Newcastle infant dialysis and ultrafiltration system (Nidus): comparison with peritoneal and conventional haemodialysis. Pediatr Nephrol 29(10):1873–1881
pubmed: 25125229 pmcid: 4167433 doi: 10.1007/s00467-014-2923-3

Auteurs

Ron Wald (R)

Division of Nephrology, St. Michael's Hospital and the University of Toronto, 61 Queen Street East, 9-140, Toronto, ON, M5C 2T2, Canada. Ron.wald@unityhealth.to.
Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, ON, Canada. Ron.wald@unityhealth.to.
ORCID: 0000-0003-4411-8169

William Beaubien-Souligny (W)

Division of Nephrology, Centre Hospitalier de L'Université de Montréal, Montréal, QC, Canada.

Rahul Chanchlani (R)

Division of Pediatric Nephrology, Department of Pediatrics, McMaster University, Hamilton, ON, Canada.

Edward G Clark (EG)

Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.

Javier A Neyra (JA)

Division of Nephrology, University of Alabama at Birmingham, Birmingham, AL, USA.

Marlies Ostermann (M)

Department of Critical Care Medicine, Guys and St. Thomas Hospital, London, UK.

Samuel A Silver (SA)

Division of Nephrology, Kingston Health Sciences Center, Queen's University, Kingston, ON, Canada.

Suvi Vaara (S)

Division of Intensive Care Medicine, Department of Anesthesiology, Intensive Care and Pain Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Alexander Zarbock (A)

Department of Anesthesiology, Intensive Care and Pain Medicine, Muenster, Germany.

Sean M Bagshaw (SM)

Department of Critical Care Medicine, University of Alberta and Alberta Health Services, Edmonton, AB, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies urogénitales › Maladies urologiques › Maladies du rein › Insuffisance rénale › Atteinte rénale aigüe › Delivering optimal renal replacement therapy...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Maladie grave › Delivering optimal renal replacement therapy...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Delivering optimal renal replacement therapy...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Établissements de santé › Unités hospitalières › Unités de soins intensifs › Delivering optimal renal replacement therapy...
questionsmedicales.fr › Thérapeutique › Traitement substitutif de l'insuffisance rénale › Delivering optimal renal replacement therapy...